Selected article for: "HBV demannosylation and immune tolerance"

Author: Hu, Song; Jiang, Li-Bin; Zou, Xiao-Jing; Yi, Wei; Tian, De-Ying
Title: Hepatitis B virus upregulates host expression of a-1,2-mannosidases via the PPARa pathway
  • Document date: 2016_11_21
  • ID: w5m23ikh_40
    Snippet: Class Ⅰ α-mannosidases could be used as drug targets to inhibit the demannosylation of HBV and prevent immune tolerance of the virus. The authors will consider all the mannosidase members and explain the correlation between HBV production, mannosidase level and HBV glycosylation status in future experiments......
    Document: Class Ⅰ α-mannosidases could be used as drug targets to inhibit the demannosylation of HBV and prevent immune tolerance of the virus. The authors will consider all the mannosidase members and explain the correlation between HBV production, mannosidase level and HBV glycosylation status in future experiments.

    Search related documents:
    Co phrase search for related documents
    • HBV demannosylation and α mannosidase: 1, 2, 3, 4
    • HBV demannosylation and immune tolerance: 1
    • HBV demannosylation and virus immune tolerance: 1
    • HBV demannosylation and virus immune tolerance prevent: 1
    • HBV demannosylation inhibit and immune tolerance: 1
    • HBV demannosylation inhibit and virus immune tolerance: 1
    • HBV demannosylation inhibit and virus immune tolerance prevent: 1
    • HBV glycosylation and α mannosidase: 1, 2
    • HBV glycosylation and mannosidase level: 1
    • HBV glycosylation status and mannosidase level: 1
    • HBV glycosylation status mannosidase level and mannosidase level: 1
    • HBV production and mannosidase level: 1
    • immune tolerance and virus immune tolerance: 1, 2
    • immune tolerance and virus immune tolerance prevent: 1